Clinical Trials Directory

Trials / Conditions / HFpEF - Heart Failure With Preserved Ejection Fraction

HFpEF - Heart Failure With Preserved Ejection Fraction

27 registered clinical trials studyying HFpEF - Heart Failure With Preserved Ejection Fraction — 21 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationDeprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
NCT07298993
Weill Medical College of Cornell UniversityPhase 4
RecruitingAlEX-DHF: Ablation and Exercise in Diastolic Heart Failure
NCT06650995
Technical University of MunichN/A
RecruitingCan Tiny Bubbles Offer an Alternative to Catheters for Assessing Pressures Inside the Heart? Investigating Ult
NCT07416279
King's College LondonN/A
RecruitingStudy of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypert
NCT07221513
Salubris Biotherapeutics IncPhase 2
RecruitingUS Benchmarking Clinical Study
NCT07215715
eMyosound SAS—
Enrolling By InvitationTesting the CHAT Program for Patients With Heart Failure
NCT06994325
Weill Medical College of Cornell UniversityN/A
RecruitingMOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fracti
NCT06670001
University of PennsylvaniaN/A
Enrolling By InvitationThe Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid Wit
NCT07077811
Affiliated Hospital of Nantong UniversityN/A
RecruitingCAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
NCT06762964
Mayo ClinicPhase 2
RecruitingHeart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences
NCT06774014
University of Leeds—
RecruitingTailored Exercise Training Study Among Adults With HFpEF
NCT07223242
University of Texas Southwestern Medical CenterPhase 2 / Phase 3
CompletedEmulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
NCT06914102
Brigham and Women's Hospital—
CompletedComparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved E
NCT06914141
Brigham and Women's Hospital—
Enrolling By InvitationSerum IGF1 on Female HFpEF Patients
NCT07015554
The University of Hong Kong-Shenzhen Hospital—
Not Yet RecruitingAtrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablatio
NCT06740539
Shanghai Chest HospitalN/A
RecruitingAI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
NCT06699056
Peerbridge Health, Inc—
Enrolling By InvitationCOR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Usi
NCT06763549
Peerbridge Health, Inc—
Active Not RecruitingRole of Colchicine as Anti-Inflammatory Therapy in HFpEF
NCT06837623
Cairo UniversityPhase 3
RecruitingValidation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension
NCT06405126
KU Leuven—
RecruitingExercise Magnetic Resonance Imaging in Patients With Obesity Associated Heart Failure
NCT06514820
University Medical Center Groningen—
RecruitingHEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
NCT05784753
University of NebraskaN/A
RecruitingCatheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
NCT06125925
The First Affiliated Hospital with Nanjing Medical UniversityN/A
UnknownAtrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Moni
NCT05745337
University of VermontPhase 1
RecruitingColchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
NCT05637398
I.M. Sechenov First Moscow State Medical UniversityPhase 1 / Phase 2
Enrolling By InvitationThe Gut Microbiota and Metabolites in HFpEF
NCT06645535
The First Affiliated Hospital with Nanjing Medical University—
CompletedPeripheral Microvascular Blood Flow in ANOCA
NCT05610410
Amsterdam UMC, location VUmc—
CompletedIMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpE
NCT04826159
Imbria Pharmaceuticals, Inc.Phase 2